295 related articles for article (PubMed ID: 30690424)
1. Surface modification of pH-sensitive honokiol nanoparticles based on dopamine coating for targeted therapy of breast cancer.
Yu R; Zou Y; Liu B; Guo Y; Wang X; Han M
Colloids Surf B Biointerfaces; 2019 May; 177():1-10. PubMed ID: 30690424
[TBL] [Abstract][Full Text] [Related]
2. Surface modification of doxorubicin-loaded nanoparticles based on polydopamine with pH-sensitive property for tumor targeting therapy.
Bi D; Zhao L; Yu R; Li H; Guo Y; Wang X; Han M
Drug Deliv; 2018 Nov; 25(1):564-575. PubMed ID: 29457518
[TBL] [Abstract][Full Text] [Related]
3. Targeted antitumor comparison study between dopamine self-polymerization and traditional synthesis for nanoparticle surface modification in drug delivery.
Zhang M; Zou Y; Zuo C; Ao H; Guo Y; Wang X; Han M
Nanotechnology; 2021 May; 32(30):. PubMed ID: 33862617
[TBL] [Abstract][Full Text] [Related]
4. Oral Delivery of Gambogenic Acid by Functional Polydopamine Nanoparticles for Targeted Tumor Therapy.
Wang B; Yuan T; Zha L; Liu Y; Chen W; Zhang C; Bao Y; Dong Q
Mol Pharm; 2021 Mar; 18(3):1470-1479. PubMed ID: 33586444
[TBL] [Abstract][Full Text] [Related]
5. Responsive functionalized MoSe
Liu Y; Wei C; Lin A; Pan J; Chen X; Zhu X; Gong Y; Yuan G; Chen L; Liu J; Luo Z
Colloids Surf B Biointerfaces; 2020 May; 189():110820. PubMed ID: 32045843
[TBL] [Abstract][Full Text] [Related]
6. Honokiol nanoparticles based on epigallocatechin gallate functionalized chitin to enhance therapeutic effects against liver cancer.
Tang P; Sun Q; Yang H; Tang B; Pu H; Li H
Int J Pharm; 2018 Jul; 545(1-2):74-83. PubMed ID: 29715531
[TBL] [Abstract][Full Text] [Related]
7. pH-Sensitive Delivery Vehicle Based on Folic Acid-Conjugated Polydopamine-Modified Mesoporous Silica Nanoparticles for Targeted Cancer Therapy.
Cheng W; Nie J; Xu L; Liang C; Peng Y; Liu G; Wang T; Mei L; Huang L; Zeng X
ACS Appl Mater Interfaces; 2017 Jun; 9(22):18462-18473. PubMed ID: 28497681
[TBL] [Abstract][Full Text] [Related]
8. Targeted delivery of honokiol by zein/hyaluronic acid core-shell nanoparticles to suppress breast cancer growth and metastasis.
Zhang Q; Wang J; Liu D; Zhu W; Guan S; Fan L; Cai D
Carbohydr Polym; 2020 Jul; 240():116325. PubMed ID: 32475585
[TBL] [Abstract][Full Text] [Related]
9. Enhancing Targeted Therapy in Hepatocellular Carcinoma through a pH-Responsive Delivery System: Folic Acid-Modified Polydopamine-Paclitaxel-Loaded Poly(3-hydroxybutyrate-
Wu M; Wang Q; Peng Y; Liang X; Lv X; Wang S; Zhong C
Mol Pharm; 2024 Feb; 21(2):581-595. PubMed ID: 38131328
[TBL] [Abstract][Full Text] [Related]
10. Polydopamine-based surface modification of mesoporous silica nanoparticles as pH-sensitive drug delivery vehicles for cancer therapy.
Chang D; Gao Y; Wang L; Liu G; Chen Y; Wang T; Tao W; Mei L; Huang L; Zeng X
J Colloid Interface Sci; 2016 Feb; 463():279-87. PubMed ID: 26550786
[TBL] [Abstract][Full Text] [Related]
11. Hyaluronic acid-modified liposomal honokiol nanocarrier: Enhance anti-metastasis and antitumor efficacy against breast cancer.
Wang J; Liu D; Guan S; Zhu W; Fan L; Zhang Q; Cai D
Carbohydr Polym; 2020 May; 235():115981. PubMed ID: 32122511
[TBL] [Abstract][Full Text] [Related]
12. A comparative study of polydopamine modified and conventional chemical synthesis method in doxorubicin liposomes form the aspect of tumor targeted therapy.
Bi D; Zhao L; Li H; Guo Y; Wang X; Han M
Int J Pharm; 2019 Mar; 559():76-85. PubMed ID: 30677481
[TBL] [Abstract][Full Text] [Related]
13. Tumor-targeting photodynamic therapy based on folate-modified polydopamine nanoparticles.
Yan S; Huang Q; Chen J; Song X; Chen Z; Huang M; Xu P; Zhang J
Int J Nanomedicine; 2019; 14():6799-6812. PubMed ID: 31692522
[TBL] [Abstract][Full Text] [Related]
14. Linker-free Gold Nanoparticle Superstructure Coated with Poly(dopamine) by Site-Specific Polymerization for Amplifying Photothermal Cancer Therapy.
Pan LL; Yang Y; Li DL; Geng WC; Jiang ZL; Song GS; Li YJ
Chem Asian J; 2020 Sep; 15(17):2742-2748. PubMed ID: 32658379
[TBL] [Abstract][Full Text] [Related]
15. Polydopamine-based surface modification of paclitaxel nanoparticles for osteosarcoma targeted therapy.
Zhao L; Bi D; Qi X; Guo Y; Yue F; Wang X; Han M
Nanotechnology; 2019 Jun; 30(25):255101. PubMed ID: 30736019
[TBL] [Abstract][Full Text] [Related]
16. Self-Assembled Dual-Targeted Epirubicin-Hybrid Polydopamine Nanoparticles for Combined Chemo-Photothermal Therapy of Triple-Negative Breast Cancer.
Li X; Zou Q; Zhang J; Zhang P; Zhou X; Yalamarty SSK; Liang X; Liu Y; Zheng Q; Gao J
Int J Nanomedicine; 2020; 15():6791-6811. PubMed ID: 32982234
[TBL] [Abstract][Full Text] [Related]
17. Biodegradable polymeric micelles coencapsulating paclitaxel and honokiol: a strategy for breast cancer therapy in vitro and in vivo.
Wang N; Wang Z; Nie S; Song L; He T; Yang S; Yang X; Yi C; Wu Q; Gong C
Int J Nanomedicine; 2017; 12():1499-1514. PubMed ID: 28260895
[TBL] [Abstract][Full Text] [Related]
18. Honokiol nanomicellar formulation produced increased oral bioavailability and anticancer effects in triple negative breast cancer (TNBC).
Godugu C; Doddapaneni R; Singh M
Colloids Surf B Biointerfaces; 2017 May; 153():208-219. PubMed ID: 28249200
[TBL] [Abstract][Full Text] [Related]
19. Fabrication of Polydopamine-Based Curcumin Nanoparticles for Chemical Stability and pH-Responsive Delivery.
Pan H; Shen X; Tao W; Chen S; Ye X
J Agric Food Chem; 2020 Mar; 68(9):2795-2802. PubMed ID: 32031786
[TBL] [Abstract][Full Text] [Related]
20. Augment the efficacy of eradicating metastatic lesions and tumor proliferation in breast cancer by honokiol-loaded pH-sensitive targeted lipid nanoparticles.
Zhang H; Li J; Yuan R; Li Y; Zhang Y; Hu X; Qu J; Chen Y; Wang Z; Xia M; Wang D
Colloids Surf B Biointerfaces; 2021 Nov; 207():112008. PubMed ID: 34333303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
